Evidence map›Paper›PMID 34120608›Full record

Trial reportMalaria journal2021

Cost of community-led larval source management and house improvement for malaria control: a cost analysis within a cluster-randomized trial in a rural district in Malawi.

Mphatso Dennis Phiri, Robert S McCann, Alinune Nathanael Kabaghe, Henk van den Berg, Tumaini Malenga, Steven Gowelo, Tinashe Tizifa, Willem Takken, Michèle van Vugt, Kamija S Phiri and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. House modifications for preventing malaria.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mphatso Dennis PhiriMalaria Epidemiology Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. mdphiri@medcol.mw.ORCID http://orcid.org/0000-0002-4072-9715
Robert S McCannLaboratory of Entomology, Wageningen University & Research, Wageningen, The Netherlands.
Alinune Nathanael KabagheSchool of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Henk van den BergLaboratory of Entomology, Wageningen University & Research, Wageningen, The Netherlands.
Tumaini MalengaSchool of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Steven GoweloSchool of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Tinashe TizifaSchool of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Willem TakkenLaboratory of Entomology, Wageningen University & Research, Wageningen, The Netherlands.
Michèle van VugtCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam-UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Kamija S PhiriSchool of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Dianne J TerlouwMalaria Epidemiology Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Eve WorrallLiverpool School of Tropical Medicine, Liverpool, UK.

Funding

FELLOWSHIP TRAINING PROGRAM IN VACCINOLOGYT32AI007524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1997 to 2026
$6.4M
Medical Research Council MR/P027873/1NIAID NIH HHS T32 AI007524Wellcome TrustWellcome Trust 205311/Z/16/Z
6 · The paper itself

Abstract

backgroundHouse improvement (HI) to prevent mosquito house entry, and larval source management (LSM) targeting aquatic mosquito stages to prevent development into adult forms, are promising complementary interventions to current malaria vector control strategies. Lack of evidence on costs and cost-effectiveness of community-led implementation of HI and LSM has hindered wide-scale adoption. This study presents an incremental cost analysis of community-led implementation of HI and LSM, in a cluster-randomized, factorial design trial, in addition to standard national malaria control interventions in a rural area (25,000 people), in southern Malawi.

methodsIn the trial, LSM comprised draining, filling, and Bacillus thuringiensis israelensis-based larviciding, while house improvement (henceforth HI) involved closing of eaves and gaps on walls, screening windows/ventilation spaces with wire mesh, and doorway modifications. Communities implemented all interventions. Costs were estimated retrospectively using the 'ingredients approach', combining 'bottom-up' and 'top-down approaches', from the societal perspective. To estimate the cost of independently implementing each intervention arm, resources shared between trial arms (e.g. overheads) were allocated to each consuming arm using proxies developed based on share of resource input quantities consumed. Incremental implementation costs (in 2017 US$) are presented for HI-only, LSM-only and HI + LSM arms. In sensitivity analyses, the effect of varying costs of important inputs on estimated costs was explored.

resultsThe total economic programme costs of community-led HI and LSM implementation was $626,152. Incremental economic implementation costs of HI, LSM and HI + LSM were estimated as $27.04, $25.06 and $33.44, per person per year, respectively. Project staff, transport and labour costs, but not larvicide or screening material, were the major cost drivers across all interventions. Costs were sensitive to changes in staff costs and population covered.

conclusionsIn the trial, the incremental economic costs of community-led HI and LSM implementation were high compared to previous house improvement and LSM studies. Several factors, including intervention design, year-round LSM implementation and low human population density could explain the high costs. The factorial trial design necessitated use of proxies to allocate costs shared between trial arms, which limits generalizability where different designs are used. Nevertheless, costs may inform planners of similar intervention packages where cost-effectiveness is known. Trial registration Not applicable. The original trial was registered with The Pan African Clinical Trials Registry on 3 March 2016, trial number PACTR201604001501493.

Indexed as

AnophelesCommunity ParticipationMalariaMosquito ControlMosquito VectorsAnimalsCluster AnalysisCosts and Cost AnalysisHumansLarvaMalawiRetrospective StudiesCommunity-ledCost analysisHouse improvementLarval source managementMalaria

Identifiers

PMID34120608
PMCPMC8200285

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.